Additional file 4 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma
FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistan
These data include the original data of in vitro and in vivo experiments. "P VS PR" means: comparing results between GEM-resistant pancreatic cancer cells and their parental sensitive ones. "TOTAL" me
PurposeThe tripartite motif-containing family member TRIM37 is involved in a number of important biological and pathological processes, and it has recently been shown to be an essential regulator of p
Figure S1. LAT2 promotes pancreatic cancer cell proliferation. (A, C) Overexpression of LAT2 in MIA PaCa-2 and PANC-1 cells promoted cell proliferation. (B, D) LAT2 knockdown suppressed cell prolifera